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In Southern California Trichophyton rubmm is encountered frequently as
the causative organism of a hyperkeratotic form of trichophytosis extremely
resistant to therapy. Cases are known to have persisted for many years in spite
of the efforts of one or more competent dermatologists. Extensive discussion
has failed to reveal any instance in which a spontaneous cure has been observed
when palms, soles or nails were involved.
In November, 1949, four patients who had been faithfully treating unsightly
and uncomfortable hyperkeratotic palms with a succession of many medica-
ments for periods of 2 to 4 years were given 5% Asterol® in alcoholic solution
for clinical trial. Within one month two patients exhibited a degree of improve-
ment estimated at 75%; the others were responding to a lesser degree. All four
were enthusiastically desirous of continuing the treatment, largely because the
medicament was entirely free of the objectionable color and odor which past
experience had led them to expect of fungicides.
Reports soon became available (1, 2) indicating that in addition to being
colorless and odorless Asterol® exhibited a low index of sensitization and was
not a primary irritant in the 5% concentration employed. It was also reported
that in alcoholic solution the drug was equally as keratolytic as a similar con-
centration of salicylic acid. A high rate of diffusion was observed. In addition
it was discovered that the compound inhibited the growth of Trichophyton
rubrum in a higher dilution (1—320,000) than when tested against other dermato-
phytes, and that even in a dilution of 1—8,000,000 the pigment usually formed
by this organism was absent, indicating an interference with its normal
growth (1).
These facts were considered sufficiently encouraging to warrant an intensive
clinical study of the activity of Asterol® in chronic invections caused by Tn-
chophyton rubrum.
NATURE OF THE MEDICAMENT
Asterol® is a substituted benzothiazole, specifically the dihydrochloride of
2-dimethylamino-6-(beta-diethylamino ethoxy)-benzothiazole. It is a white crys-
talline substance soluble in alcohol and water. A 5% solution has a pH of ap-
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proximately 2.0. The toxicity for mice is low, the LD50 being 0.375 grams per
kilo by the subcutaneous route and 0.5 grams per kilo by oral administra-
tion (1).
Several other substituted benzothiazoles have found application as fungi-
static agents in rubber and leather preservation and in agriculture; none was
found to be significantly effective against dermatophytes. Conversely Asterol®
is not fungistatic for such organisms as Penicillium or Aspergillus but is highly
effective against the pathogenic species of importance in Dermatology. Its anti-
bacterial action was found to be negligible (1).
SELECTION OF CASES
A group of 61 cases was assembled by requesting all dermatologists in this
locality to refer to a central clinic for diagnostic confirmation and treatment
patients known by them to have had trichophytosis due to T. rubrum for at
least 6 months, during at least three months of which some form of treatment
usually accepted as antifungal had been consistently administered under com-
petent dermatologic supervision without success. It was necessary to stipulate
that no patient would receive placebos alone since it seemed unfair to exact
months of cooperation from patients without affording them at least the possi-
bility of improvement. This study is admittedly deficient in this regard, since
it is not controlled in the usual manner. However, in view of the well recognized
tendency of this disease to resist treatment and the manner in which the cases
were rigidly selected to include only those previously treated unsuccessfully
for several months, it is believed that the rate of spontaneous cure to be ex-
pected within this group should be almost zero.
In all cases exhibiting some phase of the disease in the same degree bilaterally
attempts were made to institute the method of simultaneous paired comparison;
sometimes the effect of the drug was compared with an untreated area, some-
times with another fungicidal regimen. In such a chronic disease as this the
patients invariably desert what they consider to be the less effective of the
compared treatments as soon as any difference is noted, often on evidence so
slight as to be considered inconclusive. In this study the number of comparisons
of any one class was too small and the time of adherence to the program too
short to furnish evidence of statistical value. Our own clinical impressions of
such observations, however, were favorable to Asterol®.
Only those patients yielding cultures verified by us as Trichophyton rubrum
(purpureum) were included in this series. Two cases were excluded because
repeated attempts to culture the organism were unsuccessful in spite of the
fact that direct microscopic examination of specimens prepared with potassium
hydroxide revealed fungous elements and the clinical appearance was typical
of dermatomycosis. Further study was precluded by the default of the patients.
f For permission to include in this study patients referred to us by them we are indebted
to: Samuel Ayres, Jr., M.D., Samuel Ayres, III, M.D., A. Fletcher Hall, M.D., Fred Feld-
man, M.D., Norman E. Levan, M.D., Ralph Luikart, II, M.D., Marvin Knoll, M.D., Gor-
don McDonald, M.D., Ben A. Newman, M.D., Lawrence Nelson, M.D., 0. Milton Stout,
M.D.
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CLINICAL OBSERVATIONS
In some instances the infection had been present continuously for many years,
20 being the maximum stated in the case histories; the average duration for the
entire group was 5.3 years.
Duration in years —1 2 3 4 5 6 7 8 9 10 1112 13 14 15 16 17 18 19 20
Numberofpatients 11 8 4 7 9 3 7 2 2 1 0 0 1 1 2 0 0 0 1 2
There were 53 males and 8 females. Their ages ranged from 6 to 71, all but
a few were between 20 and 40 years of age.
Depending on the topographic distribution three characteristic types of in-
volvement occur in this disease: 1) On the glabrous skin of the trunk, arms and
legs or ano-genital region it exists as erythematous slightly elevated plaques
with gyrate coalescent borders; these plaques exhibit a tendency to central clear-
ing. Vesiculation is never pronounced, and a variable degree of hyperkeratosis is
Total 100%
Glabrous Skin only 21%
Palms and Soles,Wlthout Nails 28%
Nails associated with other types 51%
Fin. 1. Distribution of patients according to type of involvement
the rule. 2) Involvement of the soles and palms is characterized by erythema
and by hyperkeratosis, usually of a severe degree, diffusely covering the entire
surface; here also vesiculation is uncommon. 3) Affected nails are lusterless, dis-
colored, thickened, of heightened convexity and separated from the nail beds by
a moderate amount of friable detritus. Patients may exhibit any one type alone
or any combination of types; the tendency is however for each patient to adhere
to his own selective distribution for months or years (Fig. 1).
All patients used Asterol® topically for periods varying from 1 to 50 weeks.
Each was first given a preparation known as the "tincture" consisting of 5% of
the drug in 70% isopropyl alcohol. If there was no rapid improvement the 5%
"ointment" was then also utilized to provide more continuous chemical ac-
tivity. Patients were instructed to apply the tincture with an atomizer three
times daily, to allow the treated areas to dry, and to avoid washing the treated
areas for as long a period as possible after each application. When ointment was
also used it was applied immediately after the tincture had become dry. No
other medicament was permitted externally or internally.
Patients were under observation from 4 to 50 weeks; the average was 16.
Many of those not cured were still under treatment at the time of this report.
The infection involved only the glabrous skin of the trunk, arms, legs or ano-
genital region in 13 patients (21%). This type of the disease responded very well
to this drug. The "tincture" was sufficient without additional ointment whenever
5% Asterol in an ointment base consisting of Carbowax 4,000 35%, and polyethylene
glycol 400 55%, with 5% water.
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it was used alone and was preferred by most patients (except for use in the
perineal area) because of ease of application and freedom from greasiness. Those
who preferred the ointment however obtained equally rapid benefit. Of this
group, nine patients (69%) became entirely well in from two to six weeks; eight
have remained clear. The ninth sustained a recurrence 4 months later but again
responded completely to the same treatment. Three patients (23%) exhibited
improvement estimated to more than 50% and are continuing to rely on the
drug for a satisfactory degree of control. The remaining patient's eruption flared
immediately after beginning the treatment for reasons which are not clear since
patch testing to the ingredients was not permitted. The reaction appeared too
quickly to make allergic sensitization a likely explanation (Fig. 2).
In the remaining 48 patients (79%) the disease affected palms or soles in the
characteristic erythematous, hyperkeratotic manner. In the majority of in-
stances all four extremities were involved but all possible combinations were
Total 100%
Well 69%
lmproved,but not well 23%
Stopped treatment, IrrItated 8%
Fza. 2. Results of treatment when glabrous skin alone was involved
observed. The puzzling propensity for Trichophyton rubrum to affect one palni
or sole for years without spreading to the other was noted eighteen times. The
glabrous skin of other parts of the body was affected in varying degrees in 25
patients of this group (52%) and this portion of the infection tended to clear in
from 2 to 6 weeks; on many occasions however recurrence was noted in one or
more plaques, probably representing reinfection from the more chronic foci;
such areas usually responded when treated again. In six patients, however, the
involvement of the glabrous skin was not influenced by treatment; these were
all individuals exhibiting severe involvement of palms, soles and nails which
also resisted therapy completely.
Of the 48 patients exhibiting involvement of the palms and soles 17 (28% of
the original total of 61) had no diseased nails. This group responded to the treat-
ment more satisfactorily than the remainder and must be evaluated separately.
Four patients (24%) became well in from 2 to 4 months and have remained so.
Eleven (65%) were improved in varying degrees and two were uninfluenced
(Fig. 3).
Of the remaining 31 patients (51%) who showed involvement of nails as well
as palms and soles, one (3%) obtained a complete cure, 7 (23%) became well
except for the nail changes, 9 (29%) were improved to varying degrees and 14
(45%) seemed unaffected by the treatment (Fig. 4).
It is noteworthy that involvement of the nails reduces the effectiveness of the
treatment against the cutaneous infection. Whether this indicates that constant
reinfection occurs from this ineradicable focus or that the patient as a whole is
less resistant to the disease is not clear; our own impression favors the latter.
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The fact that many patients are known to have possessed nails infected with
this organism for years without involvement of the skin occurring at any time
seems to lend support to this view.
Only one patient (3%) succeeded in curing nails by persistent effort during
seven months. Improvement was noted in 13 others (42%); the degree of im-
provement was not usually great however. In 17 cases (55%) the nails were not
influenced by treatment. It must be admitted however, that few patients with
extensive involvement of other areas of the body can devote sufficient additional
time to their treatment schedule to allow for much debridement of the nails,
without which procedure no topical medicament can penetrate to the actively
progressing site of the infection. (Fig. 5)
Total 100%
Well 24%
lmproved,but not well 65%
Uninfluenced 12%
Fru. 3. Results of treatment when palms and soles were involved but nails were free.
Total 100%
Well 26%
lmproved,but not well 29%
Uninfluenced 45%
Pro.4. Results of treatment of involved palms and soles when nails were also diseased.
Total 100%
•WelI 3%
Improved, usually only moderately 42%,
Uninfluenced 55%
Pro. 5. Results of treatment of nails regardless of other types of involvement
Intracutaneous injection of three commercial preparations of trichophytin re-
vealed only a few positive reactors in varying degrees. No correlation could be
observed between this phenomenon and response to therapy. A special trichophy-
tin has been prepared by one of us (O.A.P.) from a composite of several strains
of Trichophyton rubrum obtained from patients in this study and is currently
being compared with the stock preparations which do not contain this factor;
results at this time are equivocal.
COMMENT
Aithough the percentage of patients obtaining cures in this series is small, it
must be recalled that this type of infection has always been extremely resistant
to therapy. The opinions of the patients who did not become well seem worthy of
mention; sixty-five per cent of this group maintain that Asterol® is a more ef-
fective medicament than any previously tried and that the freedom from color,
odor or irritational features causes them to be willing to use it indefinitely as a
means of amelioration even after hope of complete cure has been dispelled.
It must be emphasized that we still adhere to the concept that an immunologic
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mechanism yet poorly understood exerts a controlling influence on the epidemi-
ology of T. rubrum infections, and that this subject must be clarified before
good results may be had in all cases of this disease. Adequate explanation is de-
sired for the paucity of instances in which a child or spouse has been observed
to acquire the infection from a person exhibiting the disease for many years.
The tendency for the disease to remain unilateral for years suggests that it is
possible for an immunologic mechanism to be deficient only in localized areas in
an obviously susceptible individual.
Asterol® is, in our opinion a useful drug in the treatment of T. rubrum infec-
tions. It is still evident however, that the barrier interposed by hyperkeratosis
and thickened nail substance so typical of this disease limits the effectiveness of
any topical medication to such an extent that further improvements are much
to be desired. Until an immunologic approach becomes practical, a drug, enzyme
or hormone acting upon the skin from within the body would seem to offer
more promise than one topically applied.
No instance of allergic sensitization to the drug was encountered in this series.
However, the skin of one patient not included in this report who had tinea
profunda (granuloma Majocchi) due to T. rubrum became hypersensitive to
this medication after 8 months of continuous application. A report on this pa-
tient will be submitted later.
CONCLUSIONS
1. Sixty-one cases of chronic trichophytosis caused by Trichophyton rubrum
(purpureum) previously observed to be resistant to other forms of therapy were
treated with 5% Asterol® both in alcoholic solution and in water miscible oint-
ment base.
2. Lesions on the glabrous skin responded excellently; those on the palms and
soles moderately well, while involved nails were only mildly affected. These
results appear to be somewhat superior to those obtained with other medica-
ments.
3. Among those remaining uncured the drug affords sufficient improvement to
be acceptable to the majority as an ameliorative measure for long continued use.
4. Absence of objectionable color, and odor, together with a low index of irrita-
tion and of allergic sensitization make lengthy administration of this drug feasible.
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